Deals
CTI BioPharma Corporation Raises $50M at 26% Discount
|
CTI BioPharma Corporation (NASDAQ CM:CTIC) announced that it has raised $50,000,000 in a Convertible Preferred Stock transaction.
Growth Capitalist (https://growthcapitalist.com/category/deals/page/103/)
Recent growth capital transactions by pre-IPO private and public emerging growth companies
CTI BioPharma Corporation (NASDAQ CM:CTIC) announced that it has raised $50,000,000 in a Convertible Preferred Stock transaction.
NephroGenex (NASDAQ CM:NRX) announced that it has raised $5,500,001 in a Common Stock transaction.
Vascular Biogenics Limited (NASDAQ GM:VBLT) announced that it has raised $15,000,000 in a Registered Direct transaction.
Threshold Pharmaceuticals (NASDAQ CM:THLD) announced that it has secured up to $50,000,000 in an ATM (At the Market) transaction.